Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0R0UZ
|
|||
| Former ID |
DNC013404
|
|||
| Drug Name |
3-fluoro-5-(1,6-naphthyridin-7-yl)benzonitrile
|
|||
| Synonyms |
CHEMBL238390; 3-fluoro-5-(1,6-naphthyridin-7-yl)benzonitrile
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C15H8FN3
|
|||
| Canonical SMILES |
C1=CC2=CN=C(C=C2N=C1)C3=CC(=CC(=C3)C#N)F
|
|||
| InChI |
1S/C15H8FN3/c16-13-5-10(8-17)4-12(6-13)15-7-14-11(9-19-15)2-1-3-18-14/h1-7,9H
|
|||
| InChIKey |
PSQNPPVCWZBHDY-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Synthesis and SAR comparison of regioisomeric aryl naphthyridines as potent mGlu5 receptor antagonists. Bioorg Med Chem Lett. 2007 Dec 1;17(23):6525-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.